Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Exploratory biomarker analysis in EGFR mutated NSCLC patients who treated with atezolizumab plus bevacizumab and chemotherapy from phase III ATTLAS trial
- Authors
- Kim, H.; Park, S.; Kim, T. M.; Han, J-Y.; Lee, G-W.; Shim, B. Y.; Lee, Y-G.; Kim, S-W.; Ock, C-Y.; Hwang, S.; Lee, Y.; Kim, R.; Jung, H. A.; Sun, J-M.; Lee, S-H.; Ahn, J. S.; Ahn, M-J.
- Issue Date
- Dec-2024
- Publisher
- Oxford University Press
- Citation
- Annals of Oncology, v.35, pp S1636 - S1636
- Indexed
- SCIE
SCOPUS
- Journal Title
- Annals of Oncology
- Volume
- 35
- Start Page
- S1636
- End Page
- S1636
- ISSN
- 0923-7534
1569-8041
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.